Latest Schedule 13G passive stakes

Balyasny Asset Management L.P. and affiliated entities have reported an increase in their beneficial ownership of Contineum Therapeutics, Inc. Class A Common Stock to 7.14%.

Balyasny Asset Management L.P. and affiliated entities have reported a beneficial ownership of 9.99% in Cellectar Biosciences, Inc., following adjustments related to warrant exercises and ownership limitations.

Balyasny Asset Management L.P. and affiliated entities have filed an amendment to their Schedule 13G, reporting beneficial ownership of 4.99% of Camp4 Therapeutics Corp. common stock.

Ares Management Corporation's Schedule 13G filing reveals significant beneficial ownership by Ares Partners Holdco LLC and Ares Owners Holdings L.P., totaling 32.4% of Class A common stock.

Antony P. Ressler's Schedule 13G filing reveals increased beneficial ownership in Ares Management Corporation, now holding 33.1% of the class.

Axim Planning & Wealth has filed a Schedule 13G, disclosing beneficial ownership of 5.3% of EHang Holdings Limited's Class A Ordinary Shares as of June 30, 2026.

Motovance Holdings Limited and Li Wang report a combined 9.7% beneficial ownership of Park Ha Biological Technology's Class A Ordinary Shares following warrant exercise.

A significant stakeholder group, BSIV Hold 101, LP and affiliated entities, has reported beneficial ownership of 15.02% of Neptune Insurance Holdings Inc.'s Class A Common Stock.

Charles Edwin Young and Keystone Cranberry, LLC report increased beneficial ownership of Smart Sand, Inc. common stock, now holding a combined 31% stake.

Several PEAK6 affiliated entities and individuals have reported beneficial ownership of approximately 6.6% of Ring Energy, Inc.'s common stock as of June 30, 2026.

Multiple JFL-affiliated entities have jointly filed a Schedule 13G, reporting a combined beneficial ownership of 13.5% of DPC Holdings PLC's ordinary shares.

Joseph D. Samberg and his Revocable Trust report a combined beneficial ownership of 13,110,000 shares, representing 7.77% of NextNav Inc.'s common stock, as of June 30, 2026.

Wilco 63 Corp's Schedule 13G filing reveals that Wilco 63 Holding LLC, HandsOn Global Management LLC, and Par Chadha collectively beneficially own 20% of the company's Class A Ordinary Shares through convertible Class B shares.

A group of investment entities, led by Neos Partners, has disclosed beneficial ownership of over 51% of Forgent Power Solutions' Class A Common Stock.

Several entities affiliated with Millennium Management have filed a Schedule 13G, confirming their beneficial ownership of Perspective Therapeutics, Inc. common stock.

First Wilshire Securities Management, Inc. has disclosed beneficial ownership of 4.98% of Silicom Ltd's common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, disclosing a minimal beneficial ownership of 20 shares in Reviva Pharmaceuticals, representing 0.00% of the class.

Barclays PLC has filed a Schedule 13G, disclosing a minimal beneficial ownership of 20 shares in Reviva Pharmaceuticals, representing 0.00% of the class.

Millennium Management and affiliated entities have filed a Schedule 13G amendment, reporting no beneficial ownership of Zepp Health Corporation's Class A Ordinary Shares.

Barclays PLC has filed a Schedule 13G, reporting a beneficial ownership of 0.17% in Tavia Acquisition Corp's common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting a beneficial ownership of 0.17% in Tavia Acquisition Corp's common stock as of June 30, 2026.

Barclays PLC has updated its Schedule 13G filing to reflect a 0.04% beneficial ownership in Range Capital Acquisition Co. as of June 30, 2026.

Barclays PLC has updated its Schedule 13G filing to reflect a 0.04% beneficial ownership in Range Capital Acquisition Co. as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 0.6% of Soren Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 0.6% of Soren Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

David S. Nagelberg and the David S. Nagelberg 2003 Revocable Trust have increased their beneficial ownership of PAVmed Inc. common stock to 8.8% and 5.9% respectively.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Origin Materials, Inc. common stock.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Origin Materials, Inc. common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 3.8% of Launch Two Acquisition Corp.'s Class A Ordinary Shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 3.8% of Launch Two Acquisition Corp.'s Class A Ordinary Shares as of June 30, 2026.